ORIGINAL ARTICLE
Mucosal NOD2 Expression and NF-B Activation in Pediatric
Crohn’s Disease
Laura Stronati, PhD,* Anna Negroni, PhD,* Paola Merola, DSc,* Veronica Pannone, MD,
†
Osvaldo Borrelli, MD,
†
Manuela Cirulli, MD,
†
Vito Annese, MD,
‡
and Salvatore Cucchiara, MD, PhD
†
Background: Recent advances in the pathogenesis of Crohn’s
disease (CD) have suggested that an aberrant innate immune re-
sponse initiates the cascade of events leading to T-cell activation and
to disease development. NOD2 protein, which is mainly expressed
by innate immunity cells, appears to play a key role against bacteria
by triggering a host defense response through the activation of the
transcriptor factor NF-B and a consequent proinflammatory cyto-
kine production. The present study was aimed at investigating the
expression and activity of NOD2, NF-B, and of 2 proinflammatory
cytokines, TNF and IL-1, in mucosal biopsies of CD affected
children compared to healthy controls.
Methods: In all, 22 children with active CD and 10 matched
controls were entered in the study. mRNA and protein expressions
were detected using reverse-transcriptase polymerase chain reaction
(RT-PCR) and Western blot; NF-B binding activity was assessed
by electromobility gel shift assay (EMSA).
Results: NOD2 and IL-1 mRNAs were upregulated in CD chil-
dren. Protein levels of NOD2, TNF, and nuclear NF-B, as well as
the binding activity of NF-B to a consensus DNA sequence, were
significantly increased in inflamed mucosa of patients as compared
to controls. Moreover, NF-B activity was strongly upregulated in
patients also when bound to the NOD2 promoter site. No difference
was seen between patients and controls when NF-B binding activ-
ity was determined in the uninflamed tissue.
Conclusions: This study suggests that altered mechanisms regu-
lating NOD2 induction, NF-B activation and cytokine production
may contribute to dysregulate the innate immune response underly-
ing pediatric CD.
(Inflamm Bowel Dis 2008;14:295–302)
Key Words: Crohn’s disease, innate immunity, inflammation,
intestinal mucosa, children
C
rohn’s disease (CD) is a disorder characterized by
chronic inflammation of the gastrointestinal tract. Al-
though the molecular basis of the pathogenesis is not yet
clear, it has been suggested that the disease occurs in genet-
ically susceptible hosts as a consequence of a dysregulated
response of the mucosal immune system toward the commen-
sal enteric flora.
1–3
Although CD has been classically thought
to be sustained by an altered adaptive immune response, it
has recently been hypothesized that the primary defect could
be an impaired innate immune system, which relies on spe-
cific sensing of conserved pathogen-associated molecular pat-
terns (PAMPs).
4,5
Several classes of proteins, termed pattern
recognition molecules (PRMs), have been assigned to partic-
ipate in these recognition events.
6
Among them, nucleotide-
binding domain (NOD) proteins, a new class of intracellular
receptors, in particular NOD1 and NOD2, seem to have a
pivotal role in regulating inflammatory cytokine release and
in controlling the development of inflammatory reactions.
7–9
NOD2 is expressed in monocytes, macrophages, den-
dritic cells, epithelial cells, and Paneth cells. This protein
consists of 2 N-terminal caspase-activation recruitment do-
main (CARD) regions, a NOD, and a C-terminal leucin-rich-
repeat region (LRR) and is involved in the recognition of the
bacterial peptidoglycan-derived muramyl dipeptide (MDP)
through the LRR region leading to the induction of immune
response. Current evidence suggests that NOD2 interacts
with a serine threonine kinase RICK (or RIP2), leading to the
activation of NF-B, a major transcriptional regulator of
proinflammatory cytokines involved in intestinal inflamma-
tion, such as TNF and IL-1.
10 –13
Evidence of the role of the innate response in inflam-
matory bowel disease (IBD) comes from the recent associa-
tion between susceptibility to CD and NOD2 leucine-rich
repeat variants, in particular a frameshift mutation that leads
to a partial truncation of the protein in the LRR and is
associated with a defect in the MDP response.
14,15
Most studies on NOD2 function in the immune re-
sponse in CD have been mainly based on plasmid transfected
cell lines or mouse models and very few have used primary
Received for publication September 10, 2007; Accepted October 8, 2007.
From the *Section of Toxicology and Biomedical Sciences, Enea, Rome,
Italy;
†
Department of Paediatrics, University of Rome, La Sapienza, University
Hospital Umberto I, Rome, Italy,
‡
Unita ` di Gastroenterologia, Ospedale IRCCS
Casa Sollievo della Sofferenza San Giovanni Rotondo (Fg), Italy.
Reprints: Salvatore Cucchiara, MD, PhD, Professor of Pediatrics, Division
of Pediatric Gastroenterology, Head, Department of Pediatrics, University of
Rome “La Sapienza,” Viale Regina Elena, 324, 00161 Rome, Italy (e-mail:
salvatore.cucchiara@uniroma1.it).
Copyright © 2007 Crohn’s & Colitis Foundation of America, Inc.
DOI 10.1002/ibd.20332
Published online 18 December 2007 in Wiley InterScience (www.
interscience.wiley.com).
Inflamm Bowel Dis
●
Volume 14, Number 3, March 2008 295